ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:
- Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Research grants
- Employment (full or part-time)
- Ownership or partnership
- Consulting fees or other remuneration (payment)
- Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
- Receipt of royalties
- Speakers' bureau
- Other
The planning committee and faculty reported the following disclosures.
2022 disclosures coming soon
See 2021 disclosures in 2021 meeting section below.